Filters: keyword is Dose-Response Relationship [Clear All Filters]
- 2009
Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex,
Anesthesiology, vol. 110, no. 1, pp. 95-105.
- 2008
The exploration of rotenone as a toxin for inducing Parkinson's disease in rats, for application in BBB transport and PK-PD experiments,
J Pharmacol Toxicol Methods, vol. 57, no. 2, pp. 114-30.
Disease severity is a major determinant for the pharmacodynamics of propofol in critically ill patients,
Clin Pharmacol Ther, vol. 83, no. 3, pp. 443-51.
Amoxicillin pharmacokinetics in pregnant women with preterm premature rupture of the membranes,
Am J Obstet Gynecol, vol. 198, no. 1, pp. 108 e1-6.
Impact of efflux transporters and of seizures on the pharmacokinetics of oxcarbazepine metabolite in the rat brain,
Br J Pharmacol, vol. 155, no. 7, pp. 1127-38.
The influence of labour on the pharmacokinetics of intravenously administered amoxicillin in pregnant women,
Br J Clin Pharmacol, vol. 66, no. 6, pp. 866-74.
Relevance of absorption rate and lag time to the onset of action in migraine,
Clin Pharmacokinet, vol. 47, no. 2, pp. 139-46.
- 2007
Synergistic combinations of anticonvulsant agents: what is the evidence from animal experiments?,
Epilepsia, vol. 48, no. 3, pp. 412-34.
Pharmacokinetic-pharmacodynamic modelling of S(-)-atenolol in rats: reduction of isoprenaline-induced tachycardia as a continuous pharmacodynamic endpoint,
Br J Pharmacol, vol. 151, no. 3, pp. 356-66.
Population pharmacokinetic modelling of non-linear brain distribution of morphine: influence of active saturable influx and P-glycoprotein mediated efflux,
Br J Pharmacol, vol. 151, no. 5, pp. 701-12.
Animal-to-human extrapolation of the pharmacokinetic and pharmacodynamic properties of buprenorphine,
Clin Pharmacokinet, vol. 46, no. 5, pp. 433-47.
Mechanism-based pharmacokinetic-pharmacodynamic modelling of the reversal of buprenorphine-induced respiratory depression by naloxone : a study in healthy volunteers,
Clin Pharmacokinet, vol. 46, no. 11, pp. 965-80.
- 2006
A model-based approach to treatment comparison in acute migraine,
Br J Clin Pharmacol, vol. 62, no. 5, pp. 591-600.
Buprenorphine induces ceiling in respiratory depression but not in analgesia,
Br J Anaesth, vol. 96, no. 5, pp. 627-32.
Correlation between in vitro and in vivo concentration-effect relationships of naproxen in rats and healthy volunteers,
Br J Pharmacol, vol. 148, no. 4, pp. 396-404.
Naloxone reversal of buprenorphine-induced respiratory depression,
Anesthesiology, vol. 105, no. 1, pp. 51-7.
Prediction of headache response in migraine treatment,
Cephalalgia, vol. 26, no. 4, pp. 416-22.
- 2005
Comparison of the respiratory effects of intravenous buprenorphine and fentanyl in humans and rats,
Br J Anaesth, vol. 94, no. 6, pp. 825-34.
- 2004
Pharmacodynamic analysis of the anticonvulsant effects of tiagabine and lamotrigine in combination in the rat,
Epilepsia, vol. 45, no. 5, pp. 424-35.
Mechanism-based pharmacokinetic-pharmacodynamic modeling of 5-HT1A receptor agonists: estimation of in vivo affinity and intrinsic efficacy on body temperature in rats,
J Pharmacol Exp Ther, vol. 308, no. 3, pp. 1012-20.
- 2003
Anticonvulsant drugs differentially suppress individual ictal signs: a pharmacokinetic/pharmacodynamic analysis in the cortical stimulation model in the rat,
Behav Neurosci, vol. 117, no. 5, pp. 1076-85.
Cyclopentyladenosine and some of its low-efficacy derivatives inhibit striatal synaptosomal release of acetylcholine to a similar degree,
Eur J Pharmacol, vol. 481, no. 2-3, pp. 141-6.
Blood-brain barrier transport of synthetic adenosine A1 receptor agonists in vitro: structure transport relationships,
Eur J Pharm Sci, vol. 20, no. 3, pp. 347-56.
Low efficacy adenosine A1 agonists inhibit striatal acetylcholine release in rats improving central selectivity of action,
Neurosci Lett, vol. 343, no. 1, pp. 57-61.
Dose-dependent EEG effects of zolpidem provide evidence for GABA(A) receptor subtype selectivity in vivo,
J Pharmacol Exp Ther, vol. 304, no. 3, pp. 1251-7.



